Chemcon Speciality Chemicals Ltd. engages in the manufacture and sale of chemicals for pharmaceuticals and oilfield industries. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2020-10-01. The firm is engaged in producing pharmaceutical intermediates and oil well completion chemicals (completion fluids). The company is also engaged in manufacturing specialized chemicals, such as hexamethyl disilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), which are used in the pharmaceuticals industry and inorganic bromides, namely zinc bromide and calcium bromide that are used as completion fluids in the oilfield industry. Its products include hexamethyl disilazane (HMDS), chloromethyl isopropyl carbonate (CMIC) and calcium bromide liquid. The firm supply its products to domestic customers and export its products to countries including United States of America, Italy, South Korea, Germany, People’s Republic of China, Japan, United Arab Emirates, Serbia, Russia, Spain, Thailand and Malaysia.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.